Aclaris Therapeutics to Participate in Two November Healthcare Investor Conferences
November 10 2022 - 4:01PM
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage
biopharmaceutical company focused on developing novel drug
candidates for immuno-inflammatory diseases, today announced that
the company will participate in two November healthcare investor
conferences.
On Wednesday, November 16, 2022 at 5:00 PM GMT/12:00 PM EST, Dr.
Neal Walker, CEO of Aclaris, will participate in a fireside chat at
the Jefferies London Healthcare Conference in London, UK.
On Tuesday, November 29, 2022 at 9:30 AM EST, Dr. Walker will
also be participating in a fireside chat at the 34th Annual Piper
Sandler Healthcare Conference in New York, NY.
A webcast of these fireside chats may be accessed through the
“Events” page of the “Investors” section of Aclaris’ website,
www.aclaristx.com. The webcasts will be archived for at least 30
days on the Aclaris website.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical
company developing a pipeline of novel drug candidates to address
the needs of patients with immuno-inflammatory diseases who lack
satisfactory treatment options. The company has a multi-stage
portfolio of drug candidates powered by a robust R&D engine
exploring protein kinase regulation. For additional information,
please visit www.aclaristx.com.
Aclaris Therapeutics Contact:
Robert A. Doody Jr.Vice President, Investor
Relations484-639-7235rdoody@aclaristx.com
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Apr 2024 to May 2024
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From May 2023 to May 2024